Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The evolving landscape of amyloid-targeting therapies in Alzheimer's disease: progress and challenges 2026-02-28
  2. GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment 2023-11-25

Studies

2 studies carry this tag.

Date range

2023 to 2026

Top journals

  • Ageing research reviews 1
  • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The evolving landscape of amyloid-targeting therapies in Alzheimer's disease: progress and challenges

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026-02-28 Treatments

    Amyloid-targeting therapies represent the first validated disease-modifying strategy for AD but are not definitive solutions.

  2. GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Ageing research reviews 2023-11-25 Drug development

    According to the facts and figures 2023stated that 6.7 million Americans over the age of 65 have Alzheimer's disease (AD).

All topic tags with their study counts